Philips Gains FDA Marketing Clearance For Its Next-Generation Of Intellivue Guardian Solution

February 21, 2017

Netherlands–based Royal Philips has received FDA marketing clearance for the Philips Wearable Biosensor.

The device is designed to aid clinicians in the early detection of subtle signs of patient deterioration.

The device constantly measures heart rate, respiratory rate, posture and detects falls. The data is then transmitted to the device, which analyzes the combined trends of the measurements over time and notifies the appropriate clinician when preset limits are exceeded.

The device received a CE mark in 2016. — Cynthia Jessup

View today's stories